Hot selling original Italy Wholesale profhilo H+L filler injection hyaluronic acid skin booster
What is Profhilo®?
Profhilo® is the first BDDE-free stabilised medical hyaluronic acid (HA) based product for treating skin laxity.
To maximise the diffusion in the malar and sub-malar areas:
• The BAP were specifically chosen in anatomically respective areas
• The dilution phenomenon of the product itself
• 5 point per side
• Reduced pain (slowly using )
• Lower possibility of bruising or hematoma
• Reduced number of treatment sessions
• Greater patient compliance
How Does Profhilo work?
As a stabilised product Profhilo® lasts in the skin around 28 days. During this time the stimulation of 4 different types ofcollagen and elastin takes place by slow release of HA.
The stimulation results in significant tissue improvement. Therefore we cannot say that Profhilo® is a skin booster as it also hasa significant tightening / lifting effect on the tissue.
Nahyco Technology
Profhilo® is not a dermal filler or biorevitaliser - Profhilo® has opened up a new medical category - bioremodeling.
Thermal cross-linking changes the character and behavior of the HA resulting in the formation of co-operative hybrid complexes which modulate the tissues. This is also the explanation for the different biological behavior with respect to H-HA and L-HA alone. One of the main advantages is longevity. Hybrid cooperative complexes have proven to be very stable with natural hyaluronidase (BTH) digestion when compared to H-HA, widely used in biorevitalisation products, or L-HA alone resulting in the long-lasting release and the dual action of the two HA components. This dual action is ideal for remodeling skin laxity.
Advantages
In Profhilo, L-HA is released slowly from the HA hybrid complexes and therefore does not trigger the first inflammatory cytokines making it very biocompatible. It also increas¬es patient comfort during and after treatment and provides hydration to the skin especially in the epidermis – the Hydro effect.
H-HA in Profhilo provides a stable HA architecture in the dermis. This gives a volumetric effect – the Lift effect.
Another advantage of the stable co-operative hybrid complex when compared to H-HA and L-HA is the increase in the ex¬pression levels of type I and type III collagen in fibroblast and type IV and VII collagen in keratinocytes.
This results in improved skin quality and skin hydration both in the dermis and epidermis. There is also increased production of endogenous HA and elastin giving the skin a more youthful look.
